Skip to Main Content

Paper Details

Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target.
Breast
2
2023
Author NameAffiliation
Naoto T UenoThe University of Texas MD Anderson Cancer Center
Luc DirixTranslational Cancer Research Unit, GZA Hospitals & CORE, University of Antwerp, Oncology Center, GZA Hospitals Sint-Augustinus
  • 1 - 2

Datasets

Release 1.2